BioRestorative Therapies Inc

BioRestorative Therapies Inc

BRTX

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.69M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BioRestorative Therapies IncBioRestorative Therapies Inc-0.1--365%--
$-0.44

Current Fair Value

116.1% downside

Overvalued by 116.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.69 Million
Enterprise Value$574,930.00
Dividend Yield$- (-)
Earnings per Share$-31.6
Beta0.74
Outstanding Shares886,387

Return

Return on Equity-365.43%ROE
Return on Assets-238.27%
Return on Invested Capital-471.90%

Valuation & Multiples

P/E Ratio-0.12P/E Ratio
PEG0.2PEG
Price to Sales-Price to Sales
Price to Book Ratio0.9Price to Book Ratio
Enterprise Value to Revenue1.61
Enterprise Value to EBIT-0.04
Enterprise Value to Net Income-1
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
September 8, 2026
EPS Estimate
$-0.10
Average shareholder expectation
Revenue Estimate
$600,000
Average shareholder expectation

Next Earnings Call

Expected Date
September 15, 2026
EPS Estimate
$-2.00
Average shareholder expectation
Revenue Estimate
$600,000
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %29.64%▲ 22.11%
Total Invested$1.00M▲ 443.90%
Investors Holding19▲ 9.00%

ESG Score

No data

About BioRestorative Therapies Inc

5 employees
CEO: Mark Weinreb